Home | Welcome to Contract Pharma   
Last Updated Saturday, April 25 2015

Print

Breaking News

December 10, 2014
Dr. Gerberding responsible for global public policy and corporate responsibility  Read More »
December 10, 2014
Phase I study will evaluate Opdivo and mogamulizumab in solid tumors  Read More »
December 10, 2014
Werum's PAS-X V3.1.5 covers areas of API manufacturing and product warehouse  Read More »
December 9, 2014
Exemptia given subcutaneously once every other week  Read More »
December 9, 2014
Wuchterl to oversee R&D services, manufacturing, engineering, and program management   Read More »
December 9, 2014
Merck gains expanded access to Azymetric platform  Read More »
December 8, 2014
Hess and Roth take on additional executive roles  Read More »
December 8, 2014
Will collaborate with Spark to progress SPK-FIX clinical program in hemophilia B  Read More »
December 8, 2014
Aims to enhance development and commercialization efforts  Read More »
December 8, 2014
Gains antibiotic CUBICIN and late-stage anti-infective pipeline  Read More »
December 5, 2014
Says Indian manufacturers evolving to high-value, low volume work and shifting R&D programs to the West  Read More »
December 5, 2014
Aims to simplify compliance with local data privacy laws and international regulatory requirements for European customers  Read More »
December 4, 2014
Reaffirms commitment to NJ  Read More »
December 4, 2014
To impact employees and Strängnäs ops  Read More »
December 4, 2014
Will support the development and reprofiling of zolpidem using Catalent’s OSDrC OptiDose  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On